🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Day 3 at #CMLHZ25: introducing Dr Hochhaus, after receiving last night de CMLAN price. It is last day, but for sure, plenty of great sessions. THANKS @cmlan!!! It was a pleasure to meet so nice "relatives" from the CML family!!!

#ASCO25: Novartis hopes #Scemblix becomes new standard for #CML-CP CML AdvocatesNetwork clinicaltrialsarena.com/news/novartis-… via Clinical Trials Arena

Treatment-#adherence beliefs and behaviors in #patients with chronic myeloid leukemia (#CML). #ASCO2025 CML AdvocatesNetwork International CML Foundation asco.org/abstracts-pres…

🎥✨ #CMLHZ25 videos & presentations are now available online! 🌍💻 Whether you joined us in person or missed out this year, you can now watch the sessions, download the slides, and revisit all the powerful insights shared by global experts and advocates. From the latest CML

Los pacientes con #Covidpersistente necesitan desesperadamente tratamiento. Estos ensayos podrían ser útiles La medicina personalizada se volverá muy necesaria Mis #CrónicasSanitarias El Independiente de Granada cc Francisco Mera Cordero 🔴elindependientedegranada.es/ciudadania/cro…

#destacadoSEHH | Mª Victoria Mateos: “Estamos en el momento de poder hablar de curación de pacientes con mieloma” #JornadaHematoAvanza25 elmedicointeractivo.com/ma-victoria-ma… vía @elmedicoint

🎥✨ #CMLHZ25 videos & presentations are now available online! 🌍💻 You can now watch the sessions, download the slides, and revisit all the powerful insights shared by global experts and advocates. 📲 Watch now, learn, and share: 👉 cmladvocates.net/cml-horizons-2…

🌍 Buscamos 900 pacientes con LMC en: 📌 EE.UU., Canadá, Reino Unido, Francia, Alemania, Italia, España, China y Japón. 📢 ¡Ayúdanos a impulsar el cambio en el tratamiento de la LMC en todo el mundo! 🔗 Únete ahora: survey.valorem.health/cmlan-ohe-scre… CML AdvocatesNetwork International CML Foundation @sehh_es SEHH Joven

📢 Know someone living with CML? Help us reach more patients so we can gather powerful insights to improve treatment options. 💡 More participants = Stronger patient-driven research! Together, we can shape the future of CML care. 🔗 Join now: survey.valorem.health/cmlan-ohe-scre… #CMLSupport

Hochhaus on ASC4START and Asciminib’s Superior Tolerability in CML-CP Jun 23, 2025 By Jordyn Sava Fact checked by: Sabrina Serani Andreas Hochhaus International CML Foundation CML AdvocatesNetwork targetedonc.com/view/hochhaus-…

🛑🛑🛑 IMPORTANTE : desde Leucemia Mieloide Crónica .info NECESITAMOS LA COLABORACIÓN VOLUNTARIA DE PACIENTES DE #LMC PARA COMPLETAR UNA BREVE ENCUESTA: survey.valorem.health/cmlan-ohe-scre… 🛑🛑🛑 Se agradece difusión¡¡¡ International CML Foundation CML AdvocatesNetwork fcarreras @sehh_es SEHH Joven Aspher Aragón

Se agradece la difusión de esta petición!!!! #LMC

Miserables mercenaris del sistema. #INSS "La Seguridad Social deniega la incapacidad permanente a una limpiadora con cáncer porque “puede seguir trabajando” y la justicia ordena concederle la absoluta" noticiastrabajo.huffingtonpost.es/economia/pensi…

Just published: On behalf of the European LeukemiaNet, an international expert panel led presented the 2025 update of the management recommendations of chronic myeloid leukemia #CML in the journal LEUKEMIA Leukemia Journal open access. nature.com/articles/s4137…

Gracias @sehh_es por la entrevista y por poner en valor el trabajo arduo y muchas veces silencioso de tod@s los que ejercemos la #Hematologia en hospitales medianos/pequeños SEHH Joven SETH Trombosis y Hemostasia SETS Sociedad CLM de Hematología y Hemoterapia SESCAM Hospital Universitario de Valdepeñas

🇺🇸🇨🇦 CML patients in the USA and Canada - your voice is still needed! Survey deadline extended to August 25th. The CML Advocates Network is conducting a short, anonymous survey to understand which treatment side effects matter most to you. Full details attached CML AdvocatesNetwork

Last call for our next iCMLf conversation , taking place tomorrow! ⏰ Don’t miss out! CML Highlights of EHA2025 🗓️ July 22 | 14:00 CEST Prof. Tomasz Stokłosa and Prof. Andreas Hochhaus will share key insights from EHA2025. Register now: buff.ly/WB1Swtq